CASIA OpenIR
(本次检索基于用户作品认领结果)

浏览/检索结果: 共24条,第1-10条 帮助

限定条件        
已选(0)清除 条数/页:   排序方式:
A Fast and Automated FMT/XCT Reconstruction Strategy Based on Standardized Imaging Space 期刊论文
IEEE TRANSACTIONS ON MEDICAL IMAGING, 2022, 卷号: 41, 期号: 3, 页码: 657-666
作者:  An, Yu;  Bian, Chang;  Yan, Daxiang;  Wang, Hanfan;  Wang, Yu;  Du, Yang;  Tian, Jie
Adobe PDF(8285Kb)  |  收藏  |  浏览/下载:293/58  |  提交时间:2022/06/06
Imaging  Image reconstruction  Mice  In vivo  Image segmentation  Finite element analysis  Surface reconstruction  Fluorescence molecular tomography  imaging reconstruction  standardized imaging space  
Noninvasive Imaging for Assessment of the Efficacy of Therapeutic Agents for Hepatocellular Carcinoma 期刊论文
Molecular Imaging and Biology, 2019, 期号: 10.1007/s11307-019-01431-5, 页码: 1-14
作者:  Liang, Qian;  Kong, Lingxin;  Zhu, Xu;  Du, Yang;  Tian, Jie
浏览  |  Adobe PDF(3951Kb)  |  收藏  |  浏览/下载:311/109  |  提交时间:2020/06/03
Hepatocellular carcinoma  Molecular imaging  Preclinical drug evaluation  Clinical trial  Therapeutics  
Advances in molecular imaging of immune checkpoint targets in malignancies: current and future prospect 期刊论文
EUROPEAN RADIOLOGY, 2019, 卷号: 29, 期号: 8, 页码: 4294-4302
作者:  Du, Yang;  Jin, Yinhua;  Sun, Wei;  Fang, Junjie;  Zheng, Jianjun;  Tian, Jie
收藏  |  浏览/下载:261/0  |  提交时间:2019/12/16
Cancer  Immunotherapy  Molecular imaging  Immune checkpoint target  
Antitumorigenic and antiangiogenic efficacy of apatinib in liver cancer evaluated by multimodality molecular imaging 期刊论文
EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 卷号: 51, 页码: 11
作者:  Liang, Qian;  Kong, Lingxin;  Du, Yang;  Zhu, Xu;  Tian, Jie
Adobe PDF(2847Kb)  |  收藏  |  浏览/下载:443/103  |  提交时间:2019/12/16
Noninvasive imaging in cancer immunotherapy: The way to precision medicine 期刊论文
CANCER LETTERS, 2019, 卷号: 466, 页码: 13-22
作者:  Du, Yang;  Qi, Yafei;  Jin, Zhengyu;  Tian, Jie
收藏  |  浏览/下载:231/0  |  提交时间:2020/03/30
Precision medicine  Cancer  Immunotherapy  Molecular imaging  Immune checkpoint inhibitor  
Advances in Molecular Imaging of Immunotherapeutic Targets in Breast Cancer: Current and Future Prospect 期刊论文
European Radiology, 2018, 期号: NA, 页码: NA
作者:  Du Yang;  Jin Yinhua;  Sun Wei;  Fan Junjie;  Zheng Jianjun;  Tian Jie
浏览  |  Adobe PDF(6002Kb)  |  收藏  |  浏览/下载:303/76  |  提交时间:2019/02/18
Cancer, Immunotherapy, Molecular Imaging, Immune Checkpoint Target  
PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model 期刊论文
BMC CANCER, 2018, 卷号: 18, 页码: 7
作者:  Li, Yuan;  Du, Yang;  Sun, Ting;  Xue, Huadan;  Jin, Zhengyu;  Tian, Jie
浏览  |  Adobe PDF(4369Kb)  |  收藏  |  浏览/下载:428/191  |  提交时间:2019/02/18
PD-1  Zoledronic acid  Breast cancer  Therapy  Checkpoint inhibitior  
Liposomal Nanohybrid Cerasomes Targeted to PD-L1 Enable Dual-Modality Imaging and Improve Antitumor Treatments 期刊论文
Cancer Letters, 2018, 期号: 414, 页码: 230-238
作者:  Du Yang;  Xiaolong Liang;  Yuan Li;  Ting Sun;  Huadan Xue;  Zhengyu Jin;  Jie Tian
浏览  |  Adobe PDF(2955Kb)  |  收藏  |  浏览/下载:223/85  |  提交时间:2019/02/18
Programmed Cell Death Ligand-1, Near Infrared FLuorescence, Magnetic Resonance Imaging, Paclitaxel, Chemotherapy, Immunotherapy  
Liposomal nanohybrid cerasomes targeted to PD-L1 enable dual-modality imaging and improve antitumor treatments 期刊论文
CANCER LETTERS, 2018, 卷号: 414, 期号: 414, 页码: 230-238
作者:  Du, Yang;  Liang, Xiaolong;  Li, Yuan;  Sun, Ting;  Xue, Huadan;  Jin, Zhengyu;  Tian, Jie
浏览  |  Adobe PDF(3002Kb)  |  收藏  |  浏览/下载:548/226  |  提交时间:2018/01/03
Programmed Cell Death Ligand-1  Near Infrared Fluorescence  Magnetic Resonance Imaging  Paclitaxel  Chemotherapy  Immunotherapy  
Nuclear and fluorescent labeled PD-1-Liposome-DOX-64Cu/IRDye800CW allows improved breast tumor targeted imaging and therapy 期刊论文
Molecular Pharmaceutics, 2017, 卷号: 14, 期号: 11, 页码: 3978-3986
作者:  Du Yang;  Liang Xiaolong;  Li Yuan;  Sun Ting;  Jin Zhengyu;  Xue Huadan;  Tian Jie
浏览  |  Adobe PDF(4708Kb)  |  收藏  |  浏览/下载:337/72  |  提交时间:2019/02/18
Programmed Cell Death-1 (Pd-1), Near-infrared Fluorescence (Nirf) Imaging, Pet Imaging, Doxorubicin (Dox), Breast Cancer, Therapy